SCHEMBL25337486

SCHEMBL25337486

CC(C)(C)OC(=O)N1CC[C@H]1C(O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.46
CCR5 P51681 1/20 0.42
KDM4E B2RXH2 1/20 0.42
PKM P14618 1/20 0.42
CYP2D6 P10635 2/20 0.41
LMNA P02545 1/20 0.41
CYP2C9 P11712 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
ATM Q13315 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
BLM P54132 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTT P42858 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20595761 1.00 GPR119 (0.46) GPR119CCR5KDM4EPKMCYP2D6
SCHEMBL1843454 0.92 KLK7 (0.45) GPR119CYP2D6LMNACYP2C9HSD17B10
SCHEMBL13997813 0.92 KLK7 (0.45) GPR119CYP2D6LMNACYP2C9HSD17B10
SCHEMBL29997863 0.92 KLK7 (0.45) GPR119CYP2D6LMNACYP2C9HSD17B10
SCHEMBL28194949 0.92 KLK7 (0.45) GPR119CYP2D6LMNACYP2C9HSD17B10
SCHEMBL3443002 0.91 GPR119 (0.43) GPR119CYP2D6LMNACYP2C9HSD17B10
SCHEMBL25969334 0.91 GPR119 (0.43) GPR119CYP2D6LMNACYP2C9HSD17B10
SCHEMBL1795627 0.91 GPR119 (0.43) GPR119CYP2D6LMNACYP2C9HSD17B10
SCHEMBL3538308 0.90 GPR119 (0.43) GPR119CYP2D6LMNACYP2C9HSD17B10
SCHEMBL22620826 0.85 GPR119 (0.45) GPR119KDM4EPKMNR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260055133-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS WAVE LIFE SCIENCES LTD (SG) 2026-02-26 US disclosed
US-12428442-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2025-09-30 US disclosed
US-20240174710-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS WAVE LIFE SCIENCES LTD. (SG) 2024-05-30 US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
US-20220356204-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS WAVE LIFE SCIENCES LTD. (SG) 2022-11-10 US disclosed
CN-111051281-A Compounds, compositions and methods for synthesis 波涛生命科学有限公司 2020-04-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718638-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT GPR119 700/4885CCR5 1078/4885KDM4E 2103/4885
US-20220356204-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS ALKBH1, DUT, RNGTT GPR119 700/4885CCR5 1078/4885KDM4E 2103/4885
US-12428442-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT GPR119 700/4885CCR5 1078/4885KDM4E 2103/4885
US-20260055133-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS NSUN2, NSUN3, NOP2 GPR119 2320/4885CCR5 509/4885KDM4E 2283/4885
US-20240174710-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS ALKBH1, DUT, RNGTT GPR119 700/4885CCR5 1078/4885KDM4E 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.